更正：补充布拉氏酵母菌CNCM I-745可减轻肠易激综合征动物模型中的胃肠功能障碍。
Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
作者信息
Brun Paola, Scarpa Melania, Marchiori Chiara, Sarasin Gloria, Caputi Valentina, Porzionato Andrea, Giron Maria Cecilia, Palù Giorgio, Castagliuolo Ignazio
出版信息
PLoS One. 2017 Nov 17;12(11):e0188563. doi: 10.1371/journal.pone.0188563. eCollection 2017.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0181863.].
摘要
[本文更正了文章的数字对象标识符（DOI）：10.1371/journal.pone.0181863。]
相似文献
1
Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
PLoS One. 2017 Nov 17;12(11):e0188563. doi: 10.1371/journal.pone.0188563. eCollection 2017.
2
Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
PLoS One. 2017 Jul 21;12(7):e0181863. doi: 10.1371/journal.pone.0181863. eCollection 2017.
3
Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.
Benef Microbes. 2015;6(4):415-21. doi: 10.3920/BM2014.0086. Epub 2015 Feb 12.
4
The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxin.
Toxins (Basel). 2015 Oct 30;7(11):4455-67. doi: 10.3390/toxins7114455.
5
Correction: Saccharomyces Boulardii and Bacillus Subtilis B10 modulate TLRs and cytokines expression patterns in jejunum and ileum of broilers.
PLoS One. 2017 Jun 29;12(6):e0180752. doi: 10.1371/journal.pone.0180752. eCollection 2017.
6
Correction: Interaction of Saccharomyces boulardii with Salmonella enterica Serovar Typhimurium Protects Mice and Modifies T84 Cell Response to the Infection.
PLoS One. 2022 Apr 11;17(4):e0267067. doi: 10.1371/journal.pone.0267067. eCollection 2022.
7
Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
Arq Gastroenterol. 2013 Oct-Dec;50(4):304-9. doi: 10.1590/S0004-28032013000400012.
8
Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice.
Br J Nutr. 2014 May;111(9):1611-21. doi: 10.1017/S0007114513004248. Epub 2014 Feb 6.
9
A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
J Clin Gastroenterol. 2011 Sep;45(8):679-83. doi: 10.1097/MCG.0b013e318204593e.
10
Correction: Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
PLoS One. 2017 Mar 23;12(3):e0174875. doi: 10.1371/journal.pone.0174875. eCollection 2017.
引用本文的文献
1
Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome .
Front Pharmacol. 2020 Aug 31;11:1210. doi: 10.3389/fphar.2020.01210. eCollection 2020.
本文引用的文献
1
Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
PLoS One. 2017 Jul 21;12(7):e0181863. doi: 10.1371/journal.pone.0181863. eCollection 2017.
Zotero 插件